13D/13G Filings - Werewolf Therapeutics Inc. (HOWL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
4:07 pm
Sale
2024-12-3113GWerewolf Therapeutics, Inc.
HOWL
PFM Health Sciences LP2,905,465
6.500%
-493,282decrease
(-14.51%)
Filing
History
2024-11-14
4:04 pm
Sale
2024-09-3013GWerewolf Therapeutics, Inc.
HOWL
PFM Health Sciences LP3,398,747
7.800%
-69,430decrease
(-2.00%)
Filing
History
2024-11-14
11:54 am
Purchase
2024-09-3013GWerewolf Therapeutics, Inc.
HOWL
BANK OF AMERICA CORP
BAC
2,157,395
4.900%
61,314increase
(+2.93%)
Filing
History
2024-11-13
4:30 pm
Sale
2024-09-3013GWerewolf Therapeutics, Inc.
HOWL
Rubric Capital Management LP1,333,893
3.050%
-601,464decrease
(-31.08%)
Filing
History
2024-11-12
09:37 am
Purchase
2024-09-3013GWerewolf Therapeutics, Inc.
HOWL
Adage Capital Management L.P.2,000,594
4.580%
2,000,594increase
(New Position)
Filing
History
2024-05-07
4:52 pm
Purchase
2024-05-0313DWerewolf Therapeutics, Inc.
HOWL
RA Capital Management, L.P.6,192,881
14.200%
13,846increase
(+0.22%)
Filing
History
2024-02-14
5:17 pm
Purchase
2024-02-1213DWerewolf Therapeutics, Inc.
HOWL
RA Capital Management, L.P.6,179,035
15.200%
2,210,452increase
(+55.70%)
Filing
History
2024-02-14
4:06 pm
Purchase
2023-12-3113GWerewolf Therapeutics, Inc.
HOWL
PFM Health Sciences LP3,468,177
9.600%
1,646,357increase
(+90.37%)
Filing
History
2024-02-13
6:58 pm
Purchase
2023-12-3113GWerewolf Therapeutics, Inc.
HOWL
BANK OF AMERICA CORP
BAC
2,096,081
5.800%
2,096,081increase
(New Position)
Filing
History
2024-02-12
06:06 am
Purchase
2023-12-3113GWerewolf Therapeutics, Inc.
HOWL
Rubric Capital Management LP1,935,357
5.350%
99,970increase
(+5.45%)
Filing
History
2023-12-21
4:30 pm
Purchase
2023-12-1113GWerewolf Therapeutics, Inc.
HOWL
ADAGE CAPITAL PARTNERS GP L.L.C.3,034,255
8.380%
3,034,255increase
(New Position)
Filing
History
2023-02-10
4:00 pm
Purchase
2022-12-3113GWerewolf Therapeutics, Inc.
HOWL
Rubric Capital Management LP1,835,387
5.970%
1,835,387increase
(New Position)
Filing
History
2023-01-17
4:01 pm
Purchase
2023-01-0613GWerewolf Therapeutics, Inc.
HOWL
PFM Health Sciences LP1,821,820
5.300%
528,527increase
(+40.87%)
Filing
History
2023-01-17
1:20 pm
Sale
2022-12-3113GWerewolf Therapeutics, Inc.
HOWL
PFM Health Sciences LP1,293,293
4.200%
-223,733decrease
(-14.75%)
Filing
History
2023-01-10
5:11 pm
Purchase
2023-01-0613D89bio, Inc.
ETNB
RA Capital Management, L.P.6,159,054
17.960%
1,854,607increase
(+43.09%)
Filing
History
2022-08-12
4:32 pm
Purchase
2009-02-2813D89bio, Inc.
ETNB
RA Capital Management, L.P.4,304,447
14.570%
12,566increase
(+0.29%)
Filing
History
2022-05-02
4:02 pm
Purchase
2022-04-2113GWerewolf Therapeutics, Inc.
HOWL
PFM Health Sciences LP1,517,026
5.500%
1,517,026increase
(New Position)
Filing
History
2022-02-11
4:11 pm
Sale
2021-12-3113GWerewolf Therapeutics, Inc.
HOWL
James E. Flynn958,125
3.470%
-1,594,662decrease
(-62.47%)
Filing
History
2021-06-16
4:59 pm
Purchase
2009-02-2813D89bio, Inc.
ETNB
RA Capital Management, L.P.4,291,881
15.600%
4,291,881increase
(New Position)
Filing
History
2021-05-14
5:18 pm
Purchase
2021-05-0413DWerewolf Therapeutics, Inc.
HOWL
MPM BioVentures 2014, L.P. 6,731,087
24.400%
6,731,087increase
(New Position)
Filing
History
Goto 0, 1, Next